|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01649440|
Recruitment Status : Completed
First Posted : July 25, 2012
Last Update Posted : January 14, 2014
|Condition or disease|
|Normal Control SIRS Sepsis Severe Sepsis Death|
|Study Type :||Observational|
|Actual Enrollment :||65 participants|
|Observational Model:||Case Control|
|Official Title:||Systemic Metabolic Changes of Sepsis Patients Revealed by an LC-MS/MS Based Metabolomic Approach|
|Study Start Date :||July 2010|
|Primary Completion Date :||March 2012|
|Study Completion Date :||March 2012|
sepsis is defined as SIRS plus confirmed infection.
sepsis patients within 48 hours before death.
- death [ Time Frame: sepsis patients within 48 hours before death ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01649440
|Chinese PLA General Hospital|
|Beijing, Beijing, China, 100853|
|Study Director:||Lixin Xie, Dr||Department of Respiratory Diseases, Chinese PLA General Hospital|